Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety. (Q39410583)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 July 2012

Language	Label	Description	Also known as
English	Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety.	scientific article published on 3 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

fatty liver disease

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

Giovanni Troisi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Walter Verrusio

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Vincenzo Gianturco

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Alessia Bellomo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sciaila Bernardini

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Elisa D'Ottavio

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Valeria Formosa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Cristina Lo Iacono

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Benedetta Marigliano

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Vincenzo Marigliano

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

3 July 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hepatology international

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

570-576

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201789%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

https://scigraph.springernature.com/pub.10.1007/s12072-012-9387-y

0 references

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Predictive validity of a medication adherence measure in an outpatient setting

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Bile acids: regulation of apoptosis by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9387-Y

21 January 2018

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease (NAFLD): a comprehensive review

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of alpha-lipoic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology of nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26201789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39410583&oldid=1625794732"